Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
|Articles|October 19, 2020
Pharmacy Times: Week of October 19 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A recap of the exclusive content, award winners, and giveaways from the annual Women Pharmacist Day on October 12, 2020, which will be published on Thursday.
- On Friday, Pharmacy Times will publish an interview with John Beckner, senior director of strategic initiatives at the National Community Pharmacists Association, on the importance of acknowledging the critical role of pharmacists in supporting the US health care system this American Pharmacists Month.
- An interview with Amy Kallo, a PharmD student at Midwestern University, who found that working at a pharmacy during the COVID-19 pandemic brought her closer to her mentor and helped her become more aligned with her professional goals, which will be published on Tuesday.
- On Wednesday, Pharmacy Times will publish an article on the importance of smoking cessation during the coronavirus disease 2019 pandemic, including pharmacologic interventions for smoking cessation, varenicline, and combination nicotine replacement therapy.
Advertisement
Related to this article
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Emergency and ICU pharmacists would be most likely to see pneumonic plague. An expert reviews first-line agents, alternatives, and postexposure prophylaxis.
A former residency program director unpacks why this debate keeps resurfacing, and why some reasons people give for skipping residency may not hold up the way they think they do.
Eric Lawitz, MD, explains how pharmacists can discuss liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Preparing Pharmacists for Psychedelic Medicine
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5